Cargando…
Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer()()
BACKGROUND: Prostate cancers exhibit intratumor heterogeneity (ITH), like other cancer types. The ITH may affect diverse phenotypes such as treatment response, drug resistance, and clinical outcomes. It is crucial to consider ITH to understand tumorigenesis. METHODS: Genomic and transcriptomic profi...
Autores principales: | Yun, Jae Won, Lee, Soomin, Ryu, Daeun, Park, Semi, Park, Woong-Yang, Joung, Je-Gun, Jeong, Jeongyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161410/ https://www.ncbi.nlm.nih.gov/pubmed/30265975 http://dx.doi.org/10.1016/j.tranon.2018.09.003 |
Ejemplares similares
-
Clinical Relevance of Genomic Changes in Recurrent Pediatric Solid Tumors
por: Lee, Boram, et al.
Publicado: (2018) -
Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker
por: Ryu, Daeun, et al.
Publicado: (2016) -
Assessment of intratumoral heterogeneity with mutations and gene expression profiles
por: Sung, Ji-Yong, et al.
Publicado: (2019) -
Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma
por: Park, Sehhoon, et al.
Publicado: (2019) -
Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator
por: Oh, Bo Young, et al.
Publicado: (2019)